Journey Medical Corporation (DERM)
Nasdaq: DERM · Pharmaceutical Preparations · Scottsdale, AZ · filing with the SEC since 2021
Who runs Journey Medical Corporation
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Maraoui Claude
President & CEO. First filing Nov 2021, latest Apr 24, 2026, 8 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
10 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Maraoui Claude | President & CEO | Nov 2021 | Apr 24, 2026 | none |
| Benesch Joseph | CFO | Jan 2023 | Apr 24, 2026 | none |
| Alloush Ramsey | Chief Operating Officer | Apr 2025 | Apr 24, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Herskowitz Neil | director | Nov 2021 | Jul 2, 2026 | none |
| Smith Justin Adam | director | Nov 2021 | Jul 2, 2026 | none |
| Toledano Miranda Jayne | director | Nov 2021 | Jul 2, 2026 | none |
| Pearce Michael Cooper | director | Jul 2024 | Jun 26, 2026 | none |
| Rosenwald Lindsay A Md | director | Jul 2022 | Jun 26, 2026 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.